|
Alpha‐linolenic acid given as an anti‐inflammatory agent in a mouse model of colonic inflammation
|
journal
|
November 2019 |
|
Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes: HEPATOLOGY, Vol. XX, No. X 2016
|
journal
|
February 2016 |
|
Non-targeted metabolomics combined with genetic analyses identifies bile acid synthesis and phospholipid metabolism as being associated with incident type 2 diabetes
|
journal
|
July 2016 |
|
α-linolenic acid supplementation prevents exercise-induced improvements in white adipose tissue mitochondrial bioenergetics and whole-body glucose homeostasis in obese Zucker rats
|
journal
|
October 2017 |
|
Substituting dietary saturated for monounsaturated fat impairs insulin sensitivity in healthy men and women: The KANWU study
|
journal
|
March 2001 |
|
The effect of flaxseed dose on circulating concentrations of alpha-linolenic acid and secoisolariciresinol diglucoside derived enterolignans in young, healthy adults
|
journal
|
March 2015 |
|
Altered Bile Acid Metabolome in Patients with Nonalcoholic Steatohepatitis
|
journal
|
July 2015 |
|
In vitro effect of flaxseed oil and α-linolenic acid against the toxicity of lipopolysaccharide (LPS) to human umbilical vein endothelial cells
|
journal
|
September 2017 |
|
Endogenous Production of Long-Chain Polyunsaturated Fatty Acids and Metabolic Disease Risk
|
journal
|
October 2014 |
|
Effect of chloroquine on cultured fibroblasts: Release of lysosomal hydrolases and inhibition of their uptake
|
journal
|
October 1975 |
|
Non-alcoholic fatty liver disease
|
journal
|
June 2021 |
|
Evaluation of elevated plasma fatty acids as relevant factors for adult-onset asthma: The Nagahama Study
|
journal
|
January 2024 |
|
Bile acids and intestinal microbiota in autoimmune cholestatic liver diseases
|
journal
|
September 2017 |
|
Identification of a Lipokine, a Lipid Hormone Linking Adipose Tissue to Systemic Metabolism
|
journal
|
September 2008 |
|
Bile Acids Control Inflammation and Metabolic Disorder through Inhibition of NLRP3 Inflammasome
|
journal
|
October 2016 |
|
Current level of fish and omega-3 fatty acid intakes and risk of Type 2 diabetes in China
|
journal
|
December 2019 |
|
Non-alcoholic fatty liver disease is characterised by a reduced polyunsaturated fatty acid transport via free fatty acids and high-density lipoproteins (HDL)
|
journal
|
July 2023 |
|
The influence of dietary fatty acids on liver fat content and metabolism
|
journal
|
April 2019 |
|
Serum Bile Acid Profiles Improve Clinical Prediction of Nonalcoholic Fatty Liver in T2DM patients
|
journal
|
May 2021 |
|
Role of the Saturated Nonesterified Fatty Acid Palmitate in Beta Cell Dysfunction
|
journal
|
December 2012 |
|
Mechanisms of Disease: hepatic steatosis in type 2 diabetes—pathogenesis and clinical relevance
|
journal
|
June 2006 |
|
Metabolic Messengers: bile acids
|
journal
|
March 2022 |
|
FXR agonist obeticholic acid reduces hepatic inflammation and fibrosis in a rat model of toxic cirrhosis
|
journal
|
September 2016 |
|
Metabolism dysregulation induces a specific lipid signature of nonalcoholic steatohepatitis in patients
|
journal
|
April 2017 |
|
Regulation of antibacterial defense in the small intestine by the nuclear bile acid receptor
|
journal
|
February 2006 |
|
Polyunsaturated fatty acids and type 2 diabetes: Impact on the glycemic control mechanism
|
journal
|
June 2017 |
|
Treatment for 2 mo with n−3 polyunsaturated fatty acids reduces adiposity and some atherogenic factors but does not improve insulin sensitivity in women with type 2 diabetes: a randomized controlled study
|
journal
|
December 2007 |
|
Associations of serum n–3 and n–6 polyunsaturated fatty acids with prevalence and incidence of nonalcoholic fatty liver disease
|
journal
|
September 2022 |
|
Guidelines of prevention and treatment of nonalcoholic fatty liver disease (2018, China)
|
journal
|
December 2018 |
|
Saxagliptin alters bile acid profiles and yields metabolic benefits in drug‐naïve overweight or obese type 2 diabetes patient
|
journal
|
July 2019 |
|
Serum bile acid patterns are associated with the presence of NAFLD in twins, and dose‐dependent changes with increase in fibrosis stage in patients with biopsy‐proven NAFLD
|
journal
|
December 2018 |
|
Decreased plasma n6 : n3 polyunsaturated fatty acids ratio interacting with high C‐peptide promotes non‐alcoholic fatty liver disease in type 2 diabetes patients
|
journal
|
December 2020 |
|
Suppressed hepatic bile acid signalling despite elevated production of primary and secondary bile acids in NAFLD
|
journal
|
August 2017 |
|
Why and How Meet n-3 PUFA Dietary Recommendations?
|
journal
|
January 2011 |
|
Main Risk Factors of Type 2 Diabetes Mellitus with Nonalcoholic Fatty Liver Disease and Hepatocellular Carcinoma
|
journal
|
October 2021 |
|
The triglyceride glucose index is a simple and low-cost marker associated with atherosclerotic cardiovascular disease: a population-based study
|
journal
|
November 2020 |
|
Polyunsaturated fatty acid intake and incidence of type 2 diabetes in adults: a dose response meta-analysis of cohort studies
|
journal
|
March 2022 |
|
Chenodeoxycholic Acid as a Potential Prognostic Marker for Roux-en-Y Gastric Bypass in Chinese Obese Patients
|
journal
|
November 2015 |
|
Postprandial Plasma Concentrations of Individual Bile Acids and FGF-19 in Patients With Type 2 Diabetes
|
journal
|
August 2016 |
|
Fish oil supplements, oxidative status, and compliance behaviour: Regulatory challenges and opportunities
|
journal
|
December 2020 |
|
Metabolic-associated Fatty Liver Disease (MAFLD): A Multi-systemic Disease Beyond the Liver
|
journal
|
October 2021 |
|
Epidemiology of non-alcoholic and alcoholic fatty liver diseases
|
journal
|
April 2020 |
|
Clinical course of nonalcoholic fatty liver disease: an assessment of severity, progression, and outcomes
|
journal
|
December 2017 |
|
Plasma Lipidomic n-6 Polyunsaturated Fatty Acids and Type 2 Diabetes Risk in the EPIC-Potsdam Prospective Cohort Study
|
journal
|
February 2023 |
|
Nonalcoholic Fatty Liver Disease and Risk of Future Cardiovascular Events Among Type 2 Diabetic Patients
|
journal
|
December 2005 |
|
Serum fatty acid profiles associated with metabolic risk in women with polycystic ovary syndrome
|
journal
|
March 2023 |
|
Potential Nexus of Non-alcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus: Insulin Resistance Between Hepatic and Peripheral Tissues
|
journal
|
January 2019 |
|
Plasma Fatty Acid Composition Is Associated with Histological Findings of Nonalcoholic Steatohepatitis
|
journal
|
October 2022 |
|
Effects of Omega-3 Polyunsaturated Fatty Acid Supplementation on Non-Alcoholic Fatty Liver: A Systematic Review and Meta-Analysis
|
journal
|
September 2020 |
|
Omega-3 Polyunsaturated Fatty Acid: A Pharmaco-Nutraceutical Approach to Improve the Responsiveness to Ursodeoxycholic Acid
|
journal
|
July 2021 |
|
Effects of n-6 PUFAs compared with SFAs on liver fat, lipoproteins, and inflammation in abdominal obesity: a randomized controlled trial
|
journal
|
May 2012 |
|
Adipose tissue α-linolenic acid is inversely associated with insulin resistance in adults
|
journal
|
April 2016 |